Indications
Neurozyl™ Cream is indicated for the temporary relief of pain.
Contraindications
Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Warnings and precautions
For external use only. Not for ophthalmic use.
Pregnancy and breastfeeding
Use in Pregnancy: Teratogenic Effects; Pregnancy Category B. Reproduction studies have been performed for lidocaine in rats at doses up to 6.6 times the human dose and have revealed no evidence of harm to the fetus caused by lidocaine. There are, however, no adequate and well-controlled studies in pregnant women. Animal reproduction studies are not always predictive of human response. General consideration should be given to this fact before administering lidocaine to women of childbearing potential, especially during early pregnancy when maximum organogenesis takes place.
Adverse reactions
During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
Official product information
This product has no Drugs@FDA application number in our table. DailyMed holds the labels the manufacturers submit.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Neurozyl
- Active substance
- lidocaine hcl 4.12 %
- Application
- LABEL-Neurozyl
- NDC
- 59088-321-07



